Abstract
It has been suggested that the heterogeneity of TAAs in lung cancer may affect the therapeutic response and disease progression. Up to now, several tumor-associated antigen (TAA)-based cancer vaccines have been investigated in lung adenocarcinoma (LUAD); however, most of them have failed at the stage of clinical trials. The present study suggests that inter-tumoral heterogeneity of TAAs is large at single-cell resolution, while the communication between tumor cells and infiltrating T cells is closely related to the expression profile of TAAs.
| Original language | English |
|---|---|
| Article number | 41 |
| Journal | Biomarker Research |
| Volume | 9 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Dec 2021 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Lung adenocarcinoma
- Single‐cell RNA sequencing
- Tumor associated antigens
Fingerprint
Dive into the research topics of 'Single cell transcriptome revealed tumor associated antigen (TAA) profile in lung adenocarcinoma (LUAD)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver